INTRODUCTION
A large amount of cough medicine is used by the people of Indonesia. Based on 2008 data from Depok's Public Health Service, the prevalence of patients registered in Depok's primary health care facilities who suffer from cough is 4%. [1] [2] [3] This number does not include coughs caused by acute respiratory infections (ARIs). The prevalence of patients with ARI, based on the Diagnosis Health Professionals and Complaints of Residents, is 25.0%. 4 To ensure the health of the Indonesian people, the Indonesian government implemented a national health insurance program. On the implementation of the program, health care facilities were asked to refer to the National Formulary when making decisions about prescribing medicines. 1, 3 The number of cough medicines for primary health care that are listed in the National Formulary is very limited. One medicine that is in the formulary is codeine 10 mg, to be used as an antitussive. [4] [5] [6] The National Formulary has a limited inclusion of cough medicine because no evidence has been provided for the broad use of cough medicines. Nevertheless, cough medicine is prescribed in the health facilities. To determine the rational use of medicines in Indonesia, an evaluation can be done using the ATC/DDD classification. The ATC/DDD system classifies the use of medicine therapy to provide a tool to improve the quality of medicine use. [7] [8] [9] Previous studies on the use of cough medicine in Indonesia are limited. One study assessed the use of cough and cold medicines in paediatric patients under the age of 6 years. [10] [11] [12] [13] Therefore, additional research is needed to evaluate the patterns of medicine use in Indonesia using ATC/DDD. The general objective of this study was to compare the use of cough medicine in ARI patients in three primary health care facilities in Depok in 2015 based on the classification of ATC/DDD. The specific objectives of this study are comparing the quantity and the quality of the use of cough medicine in ARI patients in three primary health care facilities in Depok in 2015 expressed in DDD units and DDD/1000 patients/day, which evaluate the suitability of the use of cough medicine in ARI patients in three primary health care facilities in Depok in 2015 with the National Formulary.
METHODS
The study design was cross-sectional using retrospective data from the Primary Health Care Management Information System (SIMPUS) and the Medicine Management Information System (SIPO). Data were taken from ARI patients' prescription information, which contained cough medicine that has DDD units, in Limo Primary Health Care, Cipayung Primary Health Care, and Bojongsari Primary Health Care, from January 1 through December 31, 2015. The prescription for ARI includes the following disease codes: J00 (acute nasopharyngitis), J01 (acute sinusitis), J02 (acute pharyngitis), J06 (acute upper respiratory tract infection), J18 (bronchopneumonia), and J22 (acute lower respiratory tract infection). Cough medicine is classified by ATC classification and converted into DDD. The quantity of DDD in three primary health care facilities (Limo, Cipayung, and Bojongsari) was compared by DDD and DDD/1000 patients/day. Quality was compared by suitability of cough medicine with the National Formulary. This research was conducted from February to May 2016.
RESULTS AND DISCUSSION
Total prescriptions written were 124,427, with 22,631 prescriptions for patients with ARI. Of those, 11,481 prescriptions were for adults, and 
Demographic and social information
The total number of patients in Cipayung, Limo, and Bojongsari was 13,667, 7501, and 4731, respectively. The prevalence of male patients with ARIs was 43.29% in Cipayung, 45.72% in Limo, and 46.54% in Bojongsari. The prevalence of female patients with ARIs was 56.66% in Cipayung, 54.27% in Limo, and 53.46% in Bojongsari. As the data show, ARIs were more prevalent in females than in males. According to statistical data of Depok City in 2014, there were more males than females in the population. The prevalence of ARI patients in the age group 0-18 years was 55.17% in Cipayung, 34.70% in Limo, and 57.16% in Bojongsari. The results showed a high prevalence of ARIs in the paediatric population. This could be a result of the immature immune system in children, causing them to be more easily infected. 
Medicine use information
In the three primary health care facilities, the highest medicine use by prevalence were glyceryl guaiakolat, OBH, Ambroxol, and Ambroxol syrup. The results are provided in Table 1 . The Limo, Cipayung, and Bojongsari primary health care facilities had the same numbers for prevalence. It is important to mention that dextromethorphan, either in the tablet or syrup form, is not always used in primary health care facilities in Indonesia, and is used little compared with other cough medicines. Dextromethorphan is a precursor group that is used for the pharmaceutical industry, non-pharmaceutical industries, and the development of science and technology. 14 
Quantity of Medicine Use

Quantity of Medicine Use in DDD and DDD/1000 Patients/Day
The primary health care facility that had the largest quantity of medicines for DDD use was in Cipayung (59,136.33 g), followed by Limo (34,512.55 g) and Bojongsari (14,771.28 g). The largest quantity of medicine use for DDD/1000 patients/day for glyceryl was Cipayung (14,971 g), which means that 1.497% of patients received prescriptions for glyceryl guaiakolat every day. The largest quantity of medicine use for DDD/1000 patients/day for ambroxol was Limo (1129 g), followed by Cipayung (0,6398 g) and Bojongsari (0,4612 g). The biggest quantity of medicines use for DDD/1000 patients/day for dextromethorphan was Limo (0,0006 g). The results are shown in Table 2 . Suitability of the Medicine with the National Formulary
The amount of medicine found to be unsuitable according to the National Formulary was 34,512.55 g in Limo, 14,771.28 g in Bojongsari, and 9136.33 g in Cipayung. The results are shown in Table 3 . The results show that cough medicines are still needed to reduce symptoms despite having no evidential basis. It would be better if the medicine provision in the National Formulary was changed in consideration of the actual situation occurring in the health care facilities. The procurement of medicines in the primary health care facilities is done using e-purchasing and e-catalogues. The use of medicines in the primary health care facilities should be adapted to the standard treatment and in accordance with applicable regulations. If patients need a medicine that is not listed in the National Formulary, then it can be granted if in accordance with the medical indications and the standards of medical services whose cost is included in capitation; the cost should not be passed on to participants.
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CONCLUSION
In conclusion, all the cough medicine use in ARI patients in the three primary health care facilities in Depok in 2015 was unsuitable according to the National Formulary recommendations. Therefore, cough medicine use is needed to be evaluated further.
